The clinical impact of physical-chemical characteristics of different hyaluronic acids as a treatment for osteoarthritis.
J
J
Sánchez-Lázaro
L
L
Díaz-Gállego
D000818:Animals; D000838:Anions; D001672:Biocompatible Materials / Q000737:chemistry*; D002356:Cartilage / Q000378:metabolism; D006023:Glycoproteins / Q000737:chemistry; D006801:Humans; D006820:Hyaluronic Acid / Q000737:chemistry* / Q000627:therapeutic use*; D010003:Osteoarthritis / Q000188:drug therapy* / Q000473:pathology*; D011108:Polymers / Q000737:chemistry; D013582:Synovial Fluid / Q000378:metabolism; D013752:Tetracycline / Q000737:chemistry
D000838:Anions; D001672:Biocompatible Materials; D006023:Glycoproteins; D011108:Polymers; D006820:Hyaluronic Acid; D013752:Tetracycline